UK government announces ’emergency puberty blocker ban’ for new patients
The UK government has announced an “emergency ban” on puberty blockers for new patients. According to GOV.UK, new legislation states that “no new patients under 18 will be prescribed” gonadotrophin-releasing hormone analogues as treatment for “gender dysphoria or incongruence”. These are medicines that “consist of, or contain” buserelin, gonadorelin, goserelin, leuprorelin acetate, nafarelin or triptorelin. “The NHS stopped the routine prescription of puberty blocker treatments to under-18s following the Cass Review into gender identity services,” reads a statement on GOV.UK. “In addition, the government has also introduced indefinite restrictions to…
Read More